Industry seeks protection for Greek 'special bonds' to save hundreds of millions of euros
This article was originally published in Scrip
The Hellenic Association of Pharmaceutical Companies (SFEE) is trying to save its member companies potentially hundreds of millions of euros by ensuring that they do not lose over half the value of the Greek government bonds that pharma firms reluctantly hold.
You may also be interested in...
See how much the CEOs and R&D heads of the world’s biggest pharma companies get paid, and how those companies are performing.
Merck & Co is gradually catching up with Roche in PD-1/L1 first-line triple-negative breast cancer treatment, but its presentation at ASCO on Keynote-355 includes mixed PFS results. Overall survival data will be key to Keytruda’s competitiveness.
INFOGRAPHIC: A snapshot of the compensation packages granted to the chiefs of the world’s biggest pharma companies, along with key performance stats for the businesses they lead.